Asia Pacific Dental Membrane And Bone Graft Substitute Market
Market Size in USD Million
CAGR :
% 
USD
156.51 Million
USD
358.09 Million
2022
2030
 Forecast Period |
2023 –2030 |
 Market Size (Base Year) |
USD 156.51 Million |
 Market Size (Forecast Year) |
USD 358.09 Million |
 CAGR |
% |
| Major Markets Players |
|
Asia-Pacific Dental Membrane and Bone Graft Substitute Market, By Product Type (Dental Membranes, Dental Bone Grafts, Bio OSS, Osteograf, and Grafton), Material (Hydrogel, Collagen, Human Cells Source, Hydroxyapatite, Tricalcium Phosphate, Polytetrafluroethylene), Application (Ridge Augmentation, Socket Preservation, Periodontal Defect Regeneration, Implant Bone Regeneration, Sinus Lift, Others), End Use (Hospitals, Dental Clinics, Ambulatory Surgical Centers) – Industry Trends and Forecast to 2030.
Asia-Pacific Dental Membrane and Bone Graft Substitute Market Analysis and Size
According to data from the Centers for Disease Control and Prevention, 47.2% of adults 30 and older have periodontal disease. Age is a factor in the development of this condition; 70.1% of those 65 and older have periodontal disease. Thus the bone graft substitutes are used for preventing the gums from expanding into bones during healing and it acts as a barrier. Other factors anticipated to propel the global dental membrane and bone graft substitutes market during the forecast period include rising oral health awareness, an increase in oral disease, increased research and development (R&D) activities and increased use of resorbable dental membranes and bone graft biomaterials.
Data Bridge Market Research analyses that the dental membrane and bone graft substitute market which was USD 156.51 million in 2022, is expected to reach USD 358.09 million by 2030, at a CAGR of 10.9% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Asia-Pacific Dental Membrane and Bone Graft Substitute Market Scope and Segmentation
|
Report Metric |
Details |
|
Forecast Period |
2023 to 2030 |
|
Base Year |
2022 |
|
Historic Years |
2021 (Customizable to 2015 - 2020) |
|
Quantitative Units |
Revenue in USD Million, Volumes in Units, Pricing in USD |
|
Segments Covered |
Product Type (Dental Membranes, Dental Bone Grafts, Bio OSS, Osteograf, and Grafton), Material (Hydrogel, Collagen, Human Cells Source, Hydroxyapatite, Tricalcium Phosphate, Polytetrafluroethylene), Application (Ridge Augmentation, Socket Preservation, Periodontal Defect Regeneration, Implant Bone Regeneration, Sinus Lift, Others), End Use (Hospitals, Dental Clinics, Ambulatory Surgical Centers) |
|
Countries Covered |
China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC) |
|
Market Players Covered |
Zimmer Biomet (U.S.), Bioventus (U.S.), Synergy Orthopedics (U.S.), Ito Co., Ltd. (Japan), Boston Scientific Corporation (U.S.), BTL (Canada), Cyberonics, Inc. (U.S.), DJO LLC (U.S.), Medtronic (Ireland), Nevro Corp (U.S.), NeuroMetrix, Inc (U.S.), Abbott (U.S.), Uroplasty Inc (U.S.), Cogentix Medical (U.S.), Aleva Neurotherapeutics (Switzerland), NeuroPace Inc (U.S.), AxioBionics (U.S.), Beurer GmbH (Germany), Omron Healthcare, Inc (Japan), RS Medical (Japan), Stryker (U.S.) |
|
Market Opportunities |
|
Market Definition
Dental membranes and bone graft substitutes which are used in dental bone regeneration procedures for oral cancer patients and periodontal disease. Dental membranes are used in conjunction along with dental bone grafts to help in the cell proliferation during the regeneration process. A bone graft is a material that can be implanted and used to promote bone formation, bone healing, osseous reconstruction, and other procedures. These bone graft materials are used in bone grafting surgical procedures to replace damaged or missing bone (bone graft).
Asia-Pacific Dental Membrane and Bone Graft Substitute Market Dynamics
Drivers
- High incidence of periodontal disorders
The growing incidence of oral health disorders such as oral cancer and periodontal disease is expected to propel the dental membranes and bone graft substitute market forward. For instance, according to the article Assessment of the Status of National Oral Health Policy in India, published in 2015 by the National Center for Biotechnology Information (NCBI). The prevalence of oral diseases in India is very high, with dental caries being the most common. In people aged 5, 12, 15, 35-44, and 65-74, the prevalence is 50.0%, 52.5%, 61.4%, 79.2%, and 84.7%, respectively.
- Increased product development
Most of the manufacturers focused on the development of new products and meet the demand for effective therapeutics which is going to drive the market growth during the forecast period.
For instance, the National Oral Health Survey of India found that the prevalence of periodontal diseases was around 79.9% in people aged 65 to 74 years, while the incidence of oral cancer in India was around 12.6 per 100,000 people in 2016-2017.
Opportunities
- Increasing Elderly Population
Around the World - The World Bank estimates that there were 747,238,580 people over 60 in the world as of the end of 2021. In the upcoming years, the quantity is anticipated to rise. Older persons are more likely to experience oral health issues. Dental conditions such as edentulism are more common in older adults. Therefore, it is anticipated that throughout the forecast period, the global market for dental membrane and bone graft substitutes will rise due to the increasing acceptance of dental implants among the growing older population.
Restraints/Challenges
- Higher Cost Associated with Bone Graft Surgeries
Autografts are mainly utilized for extremely small bone defects due to their higher surgical costs and increased surgical risks, such as excessive bleeding, infection, inflammation, and discomfort. By 2021, it is estimated that 2.2 million bone transplant surgeries performed worldwide at an estimated cost of USD 664 million, with the number of operations to cure bony anomalies expected to rise by about 13% annually.
This dental membrane and bone graft substitute market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the dental membrane and bone graft substitute market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on the Dental Membrane and Bone Graft Substitute Market
The COVID-19 had a negative effect on the market for dental membrane and bone graft substitute market. Companies are experiencing a setback lockdown, causing disruptions in supply chain activities all over the world. Patient visits have decreased as a result of the worldwide implementation of lockdown restrictions. However, the situation is expected to improve as governments around the world relax regulations for resuming business operations. Furthermore, as elective surgeries and procedures resume in the near future, the demand for dental membrane and bone graft substitute is expected to rise.
Recent Developments
- In 2021, Nobel Biocare introduced the GalvoSurge Dental Implant Cleaning System, which removes biofilm from bacteria-infected titanium implants completely. It removes biofilm from inaccessible areas of any bacteria-infected titanium implant surface.
- In 2021, Datum Dental, Ltd. and its extensive portfolio of OSSIX biomaterials has been acquired by Dentsply Sirona. Datum Dental, headquartered in Israel, is well-known for its innovative dental regeneration solutions, which include the clinically superior GLYMATRIX unique technology.
Asia-Pacific Dental Membrane and Bone Graft Substitute Market Scope
The dental membrane and bone graft substitute market is segmented on the basis of product type, material, application and end-use. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product Type
- Dental Membranes
- Resorbable
- Non-resorbable
- Dental Bone Grafts
- Autograft
- Allograft
- Demineralized bone matrix
- Xenograft
- Synthetic bone graft substitutes
- Bio OSS
- Osteograf
- Grafton
Material
- Hydrogel
- Collagen
- Human Cells Source
- Hydroxyapatite
- Tricalcium Phosphate
- Polytetrafluroethylene
Application
- Ridge Augmentation
- Socket Preservation
- Periodontal Defect Regeneration
- Implant Bone Regeneration
- Sinus Lift
- Others
End Use
- Hospitals
- Dental Clinics
- Ambulatory Surgical Centers
Asia-Pacific Dental Membrane and Bone Graft Substitute Market Regional Analysis/Insights
The dental membrane and bone graft substitute market is analyzed and market size insights and trends are provided by country, product type, material, application and end-use as referenced above.
The countries covered in the dental membrane and bone graft substitute market report are China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC).
China region is expected to experience the highest CAGR during the forecast period due to the increasing incidence of dental problems. Furthermore, the market is expanding due to an increase in health-care spending and an increase in the number of elderly people. All of these factors are contributing to the market's expansion.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed base and New Technology Penetration
The dental membrane and bone graft substitute market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for dental membrane and bone graft substitute market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the dental membrane and bone graft substitute market. The data is available for historic period 2011-2021.
Competitive Landscape and Dental Membrane and Bone Graft Substitute Market Share Analysis
The dental membrane and bone graft substitute market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to dental membrane and bone graft substitute market.
Some of the major players operating in the dental membrane and bone graft substitute market are:
- Zimmer Biomet (U.S.)
- Bioventus (U.S.)
- Synergy Orthopedics (U.S.)
- Ito Co., Ltd. (Japan)
- Boston Scientific Corporation (U.S.)
- BTL (Canada)
- Cyberonics, Inc. (U.S.)
- DJO LLC (U.S.)
- Medtronic (Ireland)
- Nevro Corp (U.S.)
- NeuroMetrix, Inc (U.S.)
- Abbott (U.S.)
- Uroplasty Inc (U.S.)
- Cogentix Medical (U.S.)
- Aleva Neurotherapeutics (Switzerland)
- NeuroPace Inc (U.S.)
- AxioBionics (U.S.)
- Beurer GmbH (Germany)
- Omron Healthcare, Inc (Japan)
- RS Medical (Japan)
- Stryker (U.S.)
SKU-
Get online access to the report on the World's First Market Intelligence Cloud
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF ASIA-PACIFIC DENTAL MEMBRANE AND BONE GRAFT SUBSTITUTE MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATION
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 KEY TAKEAWAYS
2.2 ARRIVING AT THE ASIA-PACIFIC DENTAL MEMBRANE AND BONE GRAFT SUBSTITUTE MARKET SIZE
2.2.1 VENDOR POSITIONING GRID
2.2.2 TECHNOLOGY LIFE LINE CURVE
2.2.3 TRIPOD DATA VALIDATION MODEL
2.2.4 MARKET GUIDE
2.2.5 MULTIVARIATE MODELLING
2.2.6 TOP TO BOTTOM ANALYSIS
2.2.7 CHALLENGE MATRIX
2.2.8 APPLICATION COVERAGE GRID
2.2.9 STANDARDS OF MEASUREMENT
2.2.10 VENDOR SHARE ANALYSIS
2.2.11 DATA POINTS FROM KEY PRIMARY INTERVIEWS
2.2.12 DATA POINTS FROM KEY SECONDARY DATABASES
2.3 ASIA-PACIFIC DENTAL MEMBRANE AND BONE GRAFT SUBSTITUTE MARKET: RESEARCH SNAPSHOT
2.4 ASSUMPTIONS
3 MARKET OVERVIEW
3.1 DRIVERS
3.2 RESTRAINTS
3.3 OPPORTUNITIES
3.4 CHALLENGES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
5.1 PESTEL ANALYSIS
5.2 PORTER’S FIVE FORCES MODEL
6 INDUSTRY INSIGHTS
6.1 MICRO AND MACRO ECONOMIC FACTORS
6.2 PENETRATION AND GROWTH PROSPECT MAPPING
6.3 KEY PRICING STRATEGIES
6.4 INTERVIEWS WITH SPECIALIST
6.5 ANALYIS AND RECOMMENDATION
7 INTELLECTUAL PROPERTY (IP) PORTFOLIO
7.1 PATENT QUALITY AND STRENGTH
7.2 PATENT FAMILIES
7.3 LICENSING AND COLLABORATIONS
7.4 COMPETITIVE LANDSCAPE
7.5 IP STRATEGY AND MANAGEMENT
7.6 OTHER
8 COST ANALYSIS BREAKDOWN
9 TECHNONLOGY ROADMAP
10 INNOVATION TRACKER AND STRATEGIC ANALYSIS
10.1 MAJOR DEALS AND STRATEGIC ALLIANCES ANALYSIS
10.1.1 JOINT VENTURES
10.1.2 MERGERS AND ACQUISITIONS
10.1.3 LICENSING AND PARTNERSHIP
10.1.4 TECHNOLOGY COLLABORATIONS
10.1.5 STRATEGIC DIVESTMENTS
10.2 NUMBER OF PRODUCTS IN DEVELOPMENT
10.3 STAGE OF DEVELOPMENT
10.4 TIMELINES AND MILESTONES
10.5 INNOVATION STRATEGIES AND METHODOLOGIES
10.6 RISK ASSESSMENT AND MITIGATION
10.7 FUTURE OUTLOOK
11 REGULATORY COMPLIANCE
11.1 REGULATORY AUTHORITIES
11.2 REGULATORY CLASSIFICATIONS
11.2.1 CLASS I
11.2.2 CLASS II
11.2.3 CLASS III
11.3 REGULATORY SUBMISSIONS
11.4 INTERNATIONAL HARMONIZATION
11.5 COMPLIANCE AND QUALITY MANAGEMENT SYSTEMS
11.6 REGULATORY CHALLENGES AND STRATEGIES
12 REIMBURSEMENT FRAMEWORK
13 OPPUTUNITY MAP ANALYSIS
14 INSTALLED BASE DATA
15 VALUE CHAIN ANALYSIS
16 HEALTHCARE ECONOMY
16.1 HEALTHCARE EXPENDITURE
16.2 CAPITAL EXPENDITURE
16.3 CAPEX TRENDS
16.4 CAPEX ALLOCATION
16.5 FUNDING SOURCES
16.6 INDUSTRY BENCHMARKS
16.7 GDP RATION IN OVERALL GDP
16.8 HEALTHCARE SYSTEM STRUCTURE
16.9 GOVERNMENT POLICIES
16.1 ECONOMIC DEVELOPMENT
17 ASIA-PACIFIC DENTAL MEMBRANE AND BONE GRAFT SUBSTITUTE MARKET, BY TYPE
17.1 OVERVIEW
17.2 DENTAL MEMBRANE
17.2.1 SYNTHETIC
17.2.1.1. METAL AND METAL REINFORCED MEMBRANES
17.2.1.2. BILAYER POLYLACTIC ACID (PLA) MEMBRANE
17.2.1.3. PTFE MEMBRANE
17.2.1.4. OTHERS
17.2.2 NATUAL
17.2.2.1. COLLAGEN MEMBRANE
17.2.2.2. ALLOGRAFT DENTAL MEMBRANES
17.2.2.3. OTHERS
17.2.3 OTHERS
17.3 DENTAL BONE GRAFT SUBSITUTE
17.3.1 SYNTHETIC BONE GRAFT
17.3.1.1. TRICALCIUM PHOSPHATE CERAMICS
17.3.1.2. HYDROXYAPATITE
17.3.1.3. BIOACTIVE GLASS
17.3.1.4. BIPHASIC CALCIUM PHOSPHATE CERAMICS
17.3.1.5. CALCIUM PHOSPHATE CEMENT
17.3.1.6. CALCIUM-PHOSPHOSILICATE
17.3.1.7. METALS
17.3.1.7.1. MAGNESIUM (MG)
17.3.1.7.2. STRONTIUM (SR)
17.3.1.7.3. ZINC (ZN)
17.3.1.7.4. SILICON (SI)
17.3.1.8. POLYMERS
17.3.1.8.1. BY USABILITY
17.3.1.8.1.1 DEGRADABLE
17.3.1.8.1.2 NON-DEGRADABLE
17.3.1.8.2. BY TYPE
17.3.1.8.2.1 POLYLACTIC ACID
17.3.1.8.2.2 POLYGLYCOLIC ACID
17.3.1.8.2.3 POLYΕ-CAPROLACTONE
17.3.1.8.2.4 OTHERS
17.3.1.9. COMPOSITES
17.3.1.9.1. BY TYPE
17.3.1.9.1.1 NANOCRYSTALLINE HA/SILICON DIOXIDE
17.3.1.9.1.2 Β-TCP/CALCIUM SULPHATE
17.3.2 NATURAL BONE GRAFT
17.3.2.1. XENOGRAFT
17.3.2.1.1. BOVINE-DERIVED
17.3.2.1.2. PORCINE-DERIVED
17.3.2.1.3. CHITOSAN DERIVED
17.3.2.1.4. OTHERS
17.3.2.2. ALLOGRAFT
17.3.2.2.1. FRESH OR FRESH-FROZEN BONE
17.3.2.2.1.1 BY TYPE
17.3.2.2.1.1.1. DEMINERALISED BONE ALLOGRAFT
17.3.2.2.1.1.2. OCELLULAR BONE ALLOGRAFTS
17.3.2.2.1.1.3. MACHINED ALLOGRAFTS
17.3.2.2.1.2 BY USABLITY
17.3.2.2.1.2.1. BIO-REABSORBABLE
17.3.2.2.1.2.2. NON BIO-REABSORBABLE
17.3.2.2.2. FREEZE DRIED BONE ALLOGRAFT (FDBA)
17.3.2.2.2.1 BY TYPE
17.3.2.2.2.1.1. DEMINERALISED BONE ALLOGRAFT
17.3.2.2.2.1.2. OCELLULAR BONE ALLOGRAFTS
17.3.2.2.2.1.3. MACHINED ALLOGRAFTS
17.3.2.2.2.2 BY USABILITY
17.3.2.2.2.2.1. BIO-REABSORBABLE
17.3.2.2.2.2.2. NON BIO-REABSORBABLE
17.3.2.3. AUTOGRAFTS
17.3.2.3.1. MANDIBULAR SYMPHYSIS
17.3.2.3.2. MANDIBULAR RAMUS
17.3.2.3.3. EXTERNAL OBLIQUE RIDGE
17.3.2.3.4. ILIAC CREST
17.3.2.3.5. PROXIMAL ULNA
17.3.2.3.6. DISTAL RADIUS
17.3.2.4. PHYTOGENIC MATERIALS
17.3.2.4.1. GUSUIBU
17.3.2.4.2. CORAL-BASED BONE SUBSTITUTES
17.3.2.4.3. MARINE ALGAE
17.3.3 LIVE OSTEOGENIC CELLS BONE SUBSTITUTES
17.3.3.1. BIOSEED-ORAL BONE
17.3.3.2. OSTEOTRANSPLANT DENT
17.3.4 GROWTH FACTORS
17.3.4.1. TRANSFORMING GROWTH FACTOR-BETA (TGF-BETA)
17.3.4.2. PLATELET-DERIVED GROWTH FACTOR (PDGF)
17.3.4.3. FIBROBLAST GROWTH FACTORS (FGF)
17.3.4.4. BONE MORPHOGENEIC PROTEIN (BMP)
17.3.4.5. OTHERS
18 ASIA-PACIFIC DENTAL MEMBRANE AND BONE GRAFT SUBSTITUTE MARKET, BY APPLICATION
18.1 OVERVIEW
18.2 RIDGE AUGMENTATION
18.2.1 BY TYPE
18.2.1.1. DENTAL MEMBRANE
18.2.1.2. DENTAL BONE GRAFT SUBSTITUTE
18.2.2 BY SOURCE
18.2.2.1. NATURAL
18.2.2.2. SYNTHETIC
18.3 SOCKET PRESERVATION
18.3.1 BY TYPE
18.3.1.1. DENTAL MEMBRANE
18.3.1.2. DENTAL BONE GRAFT SUBSTITUTE
18.3.2 BY SOURCE
18.3.2.1. NATURAL
18.3.2.2. SYNTHETIC
18.4 PERIODONTAL DEFECT REGENERATION
18.4.1 BY TYPE
18.4.1.1. DENTAL MEMBRANE
18.4.1.2. DENTAL BONE GRAFT SUBSTITUTE
18.4.2 BY SOURCE
18.4.2.1. NATURAL
18.4.2.2. SYNTHETIC
18.5 IMPLANT BONE REGENERATION
18.5.1 BY TYPE
18.5.1.1. DENTAL MEMBRANE
18.5.1.2. DENTAL BONE GRAFT SUBSTITUTE
18.5.2 BY SOURCE
18.5.2.1. NATURAL
18.5.2.2. SYNTHETIC
18.6 SINUS LIFT
18.6.1 BY TYPE
18.6.1.1. DENTAL MEMBRANE
18.6.1.2. DENTAL BONE GRAFT SUBSTITUTE
18.6.2 BY SOURCE
18.6.2.1. NATURAL
18.6.2.2. SYNTHETIC
18.7 OTHERS
19 ASIA-PACIFIC DENTAL MEMBRANE AND BONE GRAFT SUBSTITUTE MARKET, BY SOURCE
19.1 OVERVIEW
19.2 NATURAL
19.3 SYNTHETIC
20 ASIA-PACIFIC DENTAL MEMBRANE AND BONE GRAFT SUBSTITUTE MARKET, BY USABILITY
20.1 OVERVIEW
20.2 RESORBABLE
20.3 NON-RESORBABLE
21 ASIA-PACIFIC DENTAL MEMBRANE AND BONE GRAFT SUBSTITUTE MARKET, BY MECHANISM
21.1 OVERVIEW
21.2 OSTEOCONDUCTION
21.3 OSTEOINDUCTION
21.4 OSTEOPROMOTION
21.5 OSTEOGENESIS
22 ASIA-PACIFIC DENTAL MEMBRANE AND BONE GRAFT SUBSTITUTE MARKET, BY AGE
22.1 OVERVIEW
22.2 PEDIATRICS
22.3 ADULT
22.4 GERIATRIC
23 ASIA-PACIFIC DENTAL MEMBRANE AND BONE GRAFT SUBSTITUTE MARKET, BY POPULATION TYPE
23.1 OVERVIEW
23.2 MALE
23.3 FEMALE
24 ASIA-PACIFIC DENTAL MEMBRANE AND BONE GRAFT SUBSTITUTE MARKET, BY END USER
24.1 OVERVIEW
24.2 HOSPITALS
24.3 DENTAL CLINICS
24.4 AMBULATORY SURGICAL CENTERS
24.5 RESEARCH AND DENTAL LABORATORIES
24.6 OTHERS
25 ASIA-PACIFIC DENTAL MEMBRANE AND BONE GRAFT SUBSTITUTE MARKET, BY DISTRIBUTION CHANNEL
25.1 OVERVIEW
25.2 DIRECT TENDER
25.3 RETAIL SALES
25.3.1 HOSPITAL PHARMACY
25.3.2 RETAIL PHARMACY
25.3.3 ONLINE PHARMACY
25.4 OTHERS
26 ASIA-PACIFIC DENTAL MEMBRANE AND BONE GRAFT SUBSTITUTE MARKET, SWOT AND DBMR ANALYSIS
27 ASIA-PACIFIC DENTAL MEMBRANE AND BONE GRAFT SUBSTITUTE MARKET, COMPANY LANDSCAPE
27.1 COMPANY SHARE ANALYSIS: GLOBAL
27.2 COMPANY SHARE ANALYSIS: NORTH AMERICA
27.3 COMPANY SHARE ANALYSIS: EUROPE
27.4 COMPANY SHARE ANALYSIS: ASIA-PACIFIC
27.5 MERGERS & ACQUISITIONS
27.6 NEW PRODUCT DEVELOPMENT & APPROVALS
27.7 EXPANSIONS
27.8 REGULATORY CHANGES
27.9 PARTNERSHIP AND OTHER STRATEGIC DEVELOPMENTS
28 ASIA-PACIFIC DENTAL MEMBRANE AND BONE GRAFT SUBSTITUTE MARKET, BY REGION
ASIA-PACIFIC DENTAL MEMBRANE AND BONE GRAFT SUBSTITUTE MARKET, (ALL SEGMENTATION PROVIDED ABOVE IS REPRESENTED IN THIS CHAPTER BY COUNTRY)
28.1 ASIA-PACIFIC
28.1.1 JAPAN
28.1.2 CHINA
28.1.3 SOUTH KOREA
28.1.4 INDIA
28.1.5 SINGAPORE
28.1.6 THAILAND
28.1.7 INDONESIA
28.1.8 MALAYSIA
28.1.9 PHILIPPINES
28.1.10 AUSTRALIA
28.1.11 NEW ZEALAND
28.1.12 VIETNAM
28.1.13 TAIWAN
28.1.14 REST OF ASIA-PACIFIC
28.2 KEY PRIMARY INSIGHTS: BY MAJOR COUNTRIES
29 ASIA-PACIFIC DENTAL MEMBRANE AND BONE GRAFT SUBSTITUTE MARKET, COMPANY PROFILE
29.1 BIOHORIZONS
29.1.1 COMPANY OVERVIEW
29.1.2 REVENUE ANALYSIS
29.1.3 GEOGRAPHIC PRESENCE
29.1.4 PRODUCT PORTFOLIO
29.1.5 RECENT DEVELOPMENTS
29.2 DENTSPLY SIRONA
29.2.1 COMPANY OVERVIEW
29.2.2 REVENUE ANALYSIS
29.2.3 GEOGRAPHIC PRESENCE
29.2.4 PRODUCT PORTFOLIO
29.2.5 RECENT DEVELOPMENTS
29.3 ZIMVIE INC.
29.3.1 COMPANY OVERVIEW
29.3.2 REVENUE ANALYSIS
29.3.3 GEOGRAPHIC PRESENCE
29.3.4 PRODUCT PORTFOLIO
29.3.5 RECENT DEVELOPMENTS
29.4 OSTEOGENICS BIOMEDICAL
29.4.1 COMPANY OVERVIEW
29.4.2 REVENUE ANALYSIS
29.4.3 GEOGRAPHIC PRESENCE
29.4.4 PRODUCT PORTFOLIO
29.4.5 RECENT DEVELOPMENTS
29.5 GEISTLICH PHARMA AG
29.5.1 COMPANY OVERVIEW
29.5.2 REVENUE ANALYSIS
29.5.3 GEOGRAPHIC PRESENCE
29.5.4 PRODUCT PORTFOLIO
29.5.5 RECENT DEVELOPMENTS
29.6 MEDTRONIC
29.6.1 COMPANY OVERVIEW
29.6.2 REVENUE ANALYSIS
29.6.3 GEOGRAPHIC PRESENCE
29.6.4 PRODUCT PORTFOLIO
29.6.5 RECENT DEVELOPMENTS
29.7 MAXIGEN BIOTECH INC.
29.7.1 COMPANY OVERVIEW
29.7.2 REVENUE ANALYSIS
29.7.3 GEOGRAPHIC PRESENCE
29.7.4 PRODUCT PORTFOLIO
29.7.5 RECENT DEVELOPMENTS
29.8 INSTITUT STRAUMANN AG
29.8.1 COMPANY OVERVIEW
29.8.2 REVENUE ANALYSIS
29.8.3 GEOGRAPHIC PRESENCE
29.8.4 PRODUCT PORTFOLIO
29.8.5 RECENT DEVELOPMENTS
29.9 DENTIUM
29.9.1 COMPANY OVERVIEW
29.9.2 REVENUE ANALYSIS
29.9.3 GEOGRAPHIC PRESENCE
29.9.4 PRODUCT PORTFOLIO
29.9.5 RECENT DEVELOPMENTS
29.1 BOTISS BIOMATERIALS GMBH
29.10.1 COMPANY OVERVIEW
29.10.2 REVENUE ANALYSIS
29.10.3 GEOGRAPHIC PRESENCE
29.10.4 PRODUCT PORTFOLIO
29.10.5 RECENT DEVELOPMENTS
29.11 NOVABONE
29.11.1 COMPANY OVERVIEW
29.11.2 REVENUE ANALYSIS
29.11.3 GEOGRAPHIC PRESENCE
29.11.4 PRODUCT PORTFOLIO
29.11.5 RECENT DEVELOPMENTS
29.12 CGBIO
29.12.1 COMPANY OVERVIEW
29.12.2 REVENUE ANALYSIS
29.12.3 GEOGRAPHIC PRESENCE
29.12.4 PRODUCT PORTFOLIO
29.12.5 RECENT DEVELOPMENTS
29.13 NOBEL BIOCARE SERVICES AG
29.13.1 COMPANY OVERVIEW
29.13.2 REVENUE ANALYSIS
29.13.3 GEOGRAPHIC PRESENCE
29.13.4 PRODUCT PORTFOLIO
29.13.5 RECENT DEVELOPMENTS
30 RELATED REPORTS
31 CONCLUSION
32 QUESTIONNAIRE
33 ABOUT DATA BRIDGE MARKET RESEARCH
Research Methodology
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Customization Available
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
